Back to Journals » Clinical Ophthalmology » Volume 8

Lipid-containing osmoprotective eye drops in contact lens wearers

Authors Bayhan SA, Bayhan HA

Received 26 July 2014

Accepted for publication 29 July 2014

Published 10 October 2014 Volume 2014:8 Pages 2091—2093


Checked for plagiarism Yes

Editor who approved publication: Dr Scott Fraser

Seray Aslan Bayhan, Hasan Ali Bayhan

Ophthalmology Department, Bozok University Faculty of Medicine, Yozgat, Turkey

We would like to congratulate Kaercher et al1 on their prospective study of Optive Plus (Allergan, Inc., Irvine, CA, USA) in the treatment of patients with dry eye. In this study the authors reported that Optive Plus effectively reduced the signs and symptoms of patients with all types of dry eye and they recommended the use of this artificial tear especially in lipid-deficient dry eye. We think that some important issues need more thorough discussion.

View original paper by Kaercher and colleagues.

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]